Sage Journals: Discover world-class research

Retricted access

Research article

First published 2016-09

Screening of Variations in CD22 Gene in Children with B-Precursor Acute Lymphoblastic Leukemia

Deniz Aslar Oner, Dilara Fatma Akin, Kadir Sipahi [...]

Genetic Testing and Molecular Biomarkers

Open access

Research article

First published 2021-10

227 Th-Labeled Anti-CD22 Antibody (BAY 1862864) in Relapsed/Refractory CD22-Positive Non-Hodgkin Lymphoma: A First-in-Human,Phase I Study

Ola Lindén, Andrew T. Bates, David Cunningham [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 1986-12

Selective Killing of Normal and Neoplastic Human B Cells with Anti-CD 19- and Anti-CD22-Ricin A Chain Immunotoxins

R.D. May, E.S. Vitetta, G. Moldenhauer [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Other

First published 1994-12

Chimeric LL2 (cLL2),anti-CD22

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Retricted access

Research article

First published 2013-4

Epratuzumab for Systemic Lupus Erythematosus *

DJ Wallace, DM Goldenberg

Lupus

Retricted access

Research article

First published 2003-08

Biodistribution of 131 I-,186 Re-,177 Lu-,and 88 Y-Labeled hLL2 (Epratuzumab) in Nude Mice with CD22-Positive Lymphoma

Ernst J. Postema, Cathelijne Frielink, Wim J.G. Oyen [...]

Cancer Biotherapy and Radiopharmaceuticals

Free access

Research article

First published 2014-2

B-Cell Depletion Improves Islet Allograft Survival with Anti-CD45RB

Kang Mi Lee, Heidi Yeh, Gaoping Zhao [...]

Cell Transplantation

Retricted access

Research article

First published 2013-8

Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22 + B cells

Ashraf Tabll, Yasmine El Abd, Noha G. Bader El Din [...]

Human Antibodies

Free access

Review article

First published 2015-10

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia

Musa Yilmaz, Samantha Richard, Elias Jabbour

Therapeutic Advances in Hematology

Open access

Review article

First published 2018-12

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia

J. Michael Savoy, Mary Alma Welch, Patrice E. Nasnas [...]

Therapeutic Advances in Hematology

Search results